Pharmaceutical Microbiology Department, Faculty of Pharmacy, Tanta University, Elguish Street (Medical Campus), Tanta, 31527, Egypt.
Pharmacognosy Department, Faculty of Pharmacy, Tanta University, Elguish Street (Medical Campus), Tanta, 31527, Egypt.
Inflammopharmacology. 2022 Dec;30(6):1935-1954. doi: 10.1007/s10787-022-01050-7. Epub 2022 Aug 26.
The pandemic spread of coronavirus (COVID-19) has been reported first at the end of 2019. It continues disturbing various human aspects with multiple pandemic waves showing more fatal novel variants. Now Egypt faces the sixth wave of the pandemic with controlled governmental measures. COVID-19 is an infectious respiratory disease-causing mild to moderate illness that can be progressed into life-threatening complications based on patients- and variant type-related factors. The symptoms vary from dry cough, fever to difficulty in breathing that required urgent hospitalization. Most countries have authorized their national protocols for managing manifested symptoms and thus lowering the rate of patients' hospitalization and boosting the healthcare systems. These protocols are still in use even with the development and approval of several vaccines. These protocols were instructed to aid home isolation, bed rest, dietary supplements, and additionally the administration of antipyretic, steroids, and antiviral drugs. The current review aimed to highlight the administered protocols in the Middle East, namely in Egypt and the Kingdom of Saudi Arabia demonstrating how these protocols have shown potential effectiveness in treating patients and saving many soles.
冠状病毒（COVID-19）的大流行于 2019 年底首次报告。它继续以多种新型致命变异体扰乱着人类的各个方面。现在埃及正面临着第六波大流行，政府采取了控制措施。COVID-19 是一种传染性呼吸道疾病，可引起轻度至中度疾病，但根据患者和变异体类型相关因素，可能会发展为危及生命的并发症。症状从干咳、发烧到呼吸困难不等，需要紧急住院治疗。大多数国家都批准了本国的管理症状的方案，从而降低了患者住院率并增强了医疗体系。即使开发和批准了几种疫苗，这些方案仍在使用。这些方案旨在帮助居家隔离、卧床休息、饮食补充，此外还可以使用退烧药、类固醇和抗病毒药物。本综述旨在强调中东（即埃及和沙特阿拉伯）实施的方案，展示这些方案在治疗患者和拯救生命方面的潜在效果。
